Unlock instant, AI-driven research and patent intelligence for your innovation.

New method for preparation of meptazinol hydrochloride critical impurity

A key technology of meptafol hydrochloride, which is applied in the field of preparation of key impurity compounds of meptafol hydrochloride, can solve the unqualified quality of meptafol hydrochloride, the inability to remove special impurities, and the process of meptafol hydrochloride issues of immaturity

Inactive Publication Date: 2013-12-25
BEIJING WANQUAN SUNSHINE MEDICAL TECH CO LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The drug has been on the market in 1986, but it has not been on the market in my country for nearly 30 years. The possible reasons are: 1. The process for preparing meprotamol hydrochloride is immature; Impurities cannot be removed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New method for preparation of meptazinol hydrochloride critical impurity
  • New method for preparation of meptazinol hydrochloride critical impurity
  • New method for preparation of meptazinol hydrochloride critical impurity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] To a 50 mL three-necked flask, add 6.18 g of reaction raw materials (III), add 28 mL of dichloromethane, add 3.18 g Na CO , then add 4.90 g of bromoethane, start heating to reflux, and monitor the progress of the reaction by thin layer chromatography (TLC). , reacted for 15 hours, the raw material (III) basically disappeared, stopped heating, cooled, suction filtered, washed the reaction solution with water, and concentrated the organic phase by rotary evaporation to obtain a white slightly yellow solid, which was treated with ethyl acetate-petroleum ether mixed solvent to obtain White solid, which was dried in a forced air drying oven at 40°C for 4 hours to constant weight, weighed to be 5.85 g, yield 85%, MS: 276 [M+H]+.

Embodiment 2

[0024] To a 50 mL three-necked flask, add 6.18 g of reaction raw materials (III), add 22 mL of chloroform, add 3.18 g Na CO , then add 4.90 g of bromoethane, start heating to reflux, and monitor the progress of the reaction by thin layer chromatography (TLC). , reacted for 9 hours, the raw material (III) basically disappeared, stopped heating, cooled, suction filtered, washed the reaction solution with water, and concentrated the organic phase by rotary evaporation to obtain a white slightly yellow solid, which was treated with an ethyl acetate-petroleum ether mixed solvent to obtain White solid, which was dried in a forced air drying oven at 40°C for 4 hours to constant weight, weighed to be 6.20 g, yield 90%, MS: 276 [M+H]+.

Embodiment 3

[0026] To a 50 mL three-necked flask, add 6.18 g of reaction raw materials (III), add 22 mL of chloroform, 6.62 g Na CO , chloroethane 3.22 g, 0.25 g KI, start heating to reflux, monitor the reaction by thin layer chromatography (TLC) and carry out Situation, reacted for 20 hours, the raw material (III) basically disappeared, stopped heating, cooled, suction filtered, washed the reaction solution with water, concentrated the organic phase by rotary evaporation to obtain a white slightly yellow solid, which was treated with an ethyl acetate-petroleum ether mixed solvent A white solid was obtained, and the solid was dried in a forced air drying oven at 40° C. for 4 hours to a constant weight, and the weight was 4.95 g, yield 72%, MS: 276 [M+H]+.

[0027] Example: Preparation of impurity 3-(3-ethoxyphenyl)-3-ethyl-1-methylhomopiperidine

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of pharmaceutical chemistry, relates to a new method for preparation of a meptazinol hydrochloride critical impurity, and particularly relates to the method for preparing the critical impurity 3-(3-ethoxy phenyl)-3-ethyl-1-methyl homopiperidine with 3-(3-hydroxy phenyl)-1-methyl-1H-hexahydroazepine-2-ketone (III) as a starting material and through a two-step reaction. The corresponding characterization of the compound is carried out, and the method is simple in operation.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a new method for preparing the key impurity compound (I) of meptafol hydrochloride. [0002] Background technique [0003] Compound (I) with the above structure is a key impurity of meptafol hydrochloride, and its chemical name is: 3-(3-ethoxyphenyl)-3-ethyl-1-methylhomopiperidine. [0004] The chemical name of meptafol hydrochloride is: 3-(3-ethyl-1-methyl-1H-hexahydroazepine-3-yl)phenol hydrochloride. In 1986, the racemic hydrochloride was listed in the UK, and it was recorded in the British Pharmacopoeia in 1998. It is a substitute for powerful analgesics currently used. Meptafol hydrochloride is one of the six agonist-antagonist analgesics recommended in many countries. The chemical structure of mebutaol hydrochloride is similar to that of morphine, and it is an agonist of opioid μ receptor and an antagonist of μ receptor. Most of the analgesics currently used clinica...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D223/04
Inventor 王进敏赵国磊马苏峰
Owner BEIJING WANQUAN SUNSHINE MEDICAL TECH CO LTD